Avillion, AstraZeneca asthma rescue treatment given FDA approval
Pharma Phorum
JANUARY 12, 2023
Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). Commenting on the approval, Bradley E.
Let's personalize your content